220 related articles for article (PubMed ID: 10911409)
1. Methimazole protection against oxidative stress induced by hyperthyroidism in Graves disease.
Sewerynek J; Wiktorska J; Nowak D; Lewinski A
Endocr Regul; 2000 Jun; 34(2):83-9. PubMed ID: 10911409
[TBL] [Abstract][Full Text] [Related]
2. Serum lipid levels in thyroid dysfunction with special reference to transient elevation during treatment in hyperthyroid Graves' disease.
Nishitani H; Okamura K; Noguchi S; Inoue K; Morotomi Y; Fujishima M
Horm Metab Res; 1990 Sep; 22(9):490-3. PubMed ID: 2258137
[TBL] [Abstract][Full Text] [Related]
3. Comparison of single daily dose of methimazole and propylthiouracil in the treatment of Graves' hyperthyroidism.
He CT; Hsieh AT; Pei D; Hung YJ; Wu LY; Yang TC; Lian WC; Huang WS; Kuo SW
Clin Endocrinol (Oxf); 2004 Jun; 60(6):676-81. PubMed ID: 15163329
[TBL] [Abstract][Full Text] [Related]
4. Effects of different antioxidants on lipid peroxidation in brain homogenates, induced by L-thyroxine administration in rats.
Wiktorska JA; Lewinski A; Sewerynek E
Neuro Endocrinol Lett; 2005 Dec; 26(6):704-8. PubMed ID: 16380675
[TBL] [Abstract][Full Text] [Related]
5. Thyroid function and cholesterol level: paradoxical findings in large groups of population with high cholesterol food intake.
Langer P; Kocan A; Tajtakova M; Petrik J; Koska J; Hucková M; Hanzen E; Ksinantova L; Radikova Z; Imrich R; Trnovec T; Blazicek P; Sebokova E; Klimes I
Endocr Regul; 2003 Sep; 37(3):175-80. PubMed ID: 14986723
[TBL] [Abstract][Full Text] [Related]
6. Antioxidants and methimazole in the treatment of Graves' disease: effect on urinary malondialdehyde levels.
Guerra LN; Ríos de Molina Mdel C; Miler EA; Moiguer S; Karner M; Burdman JA
Clin Chim Acta; 2005 Feb; 352(1-2):115-20. PubMed ID: 15653105
[TBL] [Abstract][Full Text] [Related]
7. Maternal thyroid function at 11-13 weeks of gestation.
Ashoor G; Kametas NA; Akolekar R; Guisado J; Nicolaides KH
Fetal Diagn Ther; 2010; 27(3):156-63. PubMed ID: 20413976
[TBL] [Abstract][Full Text] [Related]
8. Oxidative stress peripheral parameters in Graves' disease: the effect of methimazole treatment in patients with and without infiltrative ophthalmopathy.
Bednarek J; Wysocki H; Sowiński J
Clin Biochem; 2005 Jan; 38(1):13-8. PubMed ID: 15607311
[TBL] [Abstract][Full Text] [Related]
9. Ischemia-modified albumin in patients with hyperthyroidism and hypothyroidism.
Ma SG; Yang LX; Bai F; Xu W; Hong B
Eur J Intern Med; 2012 Sep; 23(6):e136-40. PubMed ID: 22863438
[TBL] [Abstract][Full Text] [Related]
10. The effect of combination therapy with propylthiouracil and cholestyramine in the treatment of Graves' hyperthyroidism.
Tsai WC; Pei D; Wang TF; Wu DA; Li JC; Wei CL; Lee CH; Chen SP; Kuo SW
Clin Endocrinol (Oxf); 2005 May; 62(5):521-4. PubMed ID: 15853819
[TBL] [Abstract][Full Text] [Related]
11. In vitro suppression of anti-TSH receptor antibody by autologous anti-idiotypic antibody in patients with Graves' disease.
Balázs C; Molnár I
Acta Microbiol Immunol Hung; 1995; 42(2):163-9. PubMed ID: 7551709
[TBL] [Abstract][Full Text] [Related]
12. [Effect of thyroxine upon prevention of recurrence of Graves' disease treated with antithyroid drugs].
Wu G; Jie Y; Situ Y
Zhonghua Yi Xue Za Zhi; 2001 Mar; 81(5):274-5. PubMed ID: 11798886
[TBL] [Abstract][Full Text] [Related]
13. [Thyroid function and lipid metabolism in patients with anorexia nervosa].
Smorawińska A; Korman E; Rajewski A; Karlik A
Psychiatr Pol; 2003; 37(1):39-46. PubMed ID: 12685302
[TBL] [Abstract][Full Text] [Related]
14. Effect of 1 alpha-hydroxyvitamin D3 on serum levels of thyroid hormones in hyperthyroid patients with untreated Graves' disease.
Kawakami-Tani T; Fukawa E; Tanaka H; Abe Y; Makino I
Metabolism; 1997 Oct; 46(10):1184-8. PubMed ID: 9322804
[TBL] [Abstract][Full Text] [Related]
15. Ischemia-modified albümin and malondialdehyde levels in patients with overt and subclinical hyperthyroidism: effects of treatment on oxidative stress.
Erem C; Suleyman AK; Civan N; Mentese A; Nuhoglu İ; Uzun A; Ersoz HO; Deger O
Endocr J; 2015; 62(6):493-501. PubMed ID: 25843331
[TBL] [Abstract][Full Text] [Related]
16. [The effect of one-month antithyroid therapy on peripheral metabolism of reactive oxygen species in Graves' disease with infiltrative ophthalmopathy].
Bednarek J; Wysocki H; Sowiński J
Przegl Lek; 2004; 61(8):841-4. PubMed ID: 15789912
[TBL] [Abstract][Full Text] [Related]
17. Serum total antioxidant status and lipid peroxidation marker malondialdehyde levels in overt and subclinical hypothyroidism.
Torun AN; Kulaksizoglu S; Kulaksizoglu M; Pamuk BO; Isbilen E; Tutuncu NB
Clin Endocrinol (Oxf); 2009 Mar; 70(3):469-74. PubMed ID: 18727709
[TBL] [Abstract][Full Text] [Related]
18. [Serum thyroxine and triiodothyronine levels after a single dose and after 2-month-long thiamazole treatment of Graves' disease with reference to drug's pharmacokinetics].
Syrenicz A
Ann Acad Med Stetin; 1990; 36():133-52. PubMed ID: 2099104
[TBL] [Abstract][Full Text] [Related]
19. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity.
Erem C
Clin Endocrinol (Oxf); 2006 Mar; 64(3):323-9. PubMed ID: 16487444
[TBL] [Abstract][Full Text] [Related]
20. Weight loss through gastric banding: effects on TSH and thyroid hormones in obese subjects with normal thyroid function.
Dall'Asta C; Paganelli M; Morabito A; Vedani P; Barbieri M; Paolisso G; Folli F; Pontiroli AE
Obesity (Silver Spring); 2010 Apr; 18(4):854-7. PubMed ID: 19834461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
